Lantern Pharma Inc (LTRN) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-0.25x
Lantern Pharma Inc (LTRN) has a Cash Flow-to-Debt Ratio of -0.25x as of June 2026, meaning its operating cash flow of $-2.94 Million could theoretically repay 0% of its total liabilities ($11.82 Million) in one year. See Lantern Pharma Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.25x
Operating CF / Total Liabilities
Operating Cash Flow
$-2.94 Million
USD
Total Liabilities
$11.82 Million
USD
Data as of
Jun 2026
Most recent filing
Lantern Pharma Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Lantern Pharma Inc across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Lantern Pharma Inc.
Annual Cash Flow-to-Debt Ratio for Lantern Pharma Inc (2018–2025)
Year-by-year debt coverage analysis for Lantern Pharma Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.48x | $-15.68 Million | $4.50 Million | ▲ +14.3% |
| 2024 | -4.06x | $-17.81 Million | $4.38 Million | ▲ +22.4% |
| 2023 | -5.24x | $-14.35 Million | $2.74 Million | ▼ -14.8% |
| 2022 | -4.56x | $-12.77 Million | $2.80 Million | ▼ -2.5% |
| 2021 | -4.45x | $-10.59 Million | $2.38 Million | ▲ +47.9% |
| 2020 | -8.55x | $-5.65 Million | $660.84K | ▼ -96.6% |
| 2019 | -4.35x | $-2.13 Million | $489.29K | ▼ -122.9% |
| 2018 | -1.95x | $-1.27 Million | $651.63K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.